von Tobias Borgers | Sep. 14, 2021 | Boehringer
INGELHEIM, Germany & HOUSTON–(BUSINESS WIRE)–Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced the extension and expansion of their joint Virtual Research and Development Center (VRDC) to explore new molecules...
von Tobias Borgers | Sep. 14, 2021 | Abbvie
Copenhagen, Denmark; North Chicago, Ill. – Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) announced The Lancet published the results of the dose escalation part of the phase 1/2 EPCORE NHL-1 first-in-human (FIH) dose escalation and cohort expansion clinical...
von Tobias Borgers | Sep. 11, 2021 | Allgemein
REDWOOD CITY, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both...
von Tobias Borgers | Aug. 29, 2021 | Continuous Manufacturing
Construction of a new medicines manufacturing innovation centre that will solve major pharmaceutical industry challenges and accelerate access to affordable medicines has topped out. Located in Renfrewshire, at the heart of the emerging Advanced Manufacturing...
von Tobias Borgers | Aug. 29, 2021 | Bayer
Bayer’s history in China dates back more than a century. Bayer Bayer has business locations in 83 countries around the world. Overall, pharmaceuticals are its second-biggest business after crop science, accounting for 41.6% of sales of about 17 billion...
